河北省医药制造业竞争力研究
发布时间：2018-08-17 17:49
【摘要】：医药行业不仅是高新技术产业以及战略新兴产业的重要组成部分，还是按国际标准划分的15类国际化产业和世界贸易增长最快的朝阳产业之一，有着高技术、高投入、高风险和高回报的特点。同时，医药行业是河北省十大支柱产业之一，是重要的发展行业。在河北省的医药行业中，医药制造业占主导地位，本文研究重点是河北省的医药制造业。 在当前国内外经济形势错综复杂、市场竞争日益激烈和药品政策性限价、各地“双信封”制基药招标政策等不确定因素下，河北省的医药制造业依然保持了规模稳定增长，创新与结构调整初显成效的特点。但同时也面临着许多挑战，经济总量在全国位次后移，效益明显下滑，出口形势也不明朗。在《河北省医药产业发展“十二五”规划》出台，，大力发展医药行业的情况下，研究河北省如何应对复杂的外界经济环境，调整其发展路径保证收利同增有着重要的意义。 本文在产业竞争力相关理论的基础上，首先对如何研究河北省医药制造业的竞争力进行了界定；然后运用综合比较优势系数法、偏离-份额法以及因子分析法对河北省医药制造业的竞争力进行了分析；最后又引用华药集团的案例，验证了河北省医药制造业发展过程中的存在的问题。研究发现河北省医药制造业存在的问题有规模优势不明显，结构仍需调整；效益水平大幅下滑；创新水平不高等。 最后得出了以下结论：河北省医药制造业相较于其他主导产业不具有比较优势；河北省化学药品原料药制造业和中成药生产制造业不具备竞争优势，化学药品制剂业具有较强的竞争力，其他行业虽然具有一定的竞争力但规模很小；与医药强省相比，河北省医药制造业的竞争力处于劣势地位。并针对以上结论，对今后的河北省发展医药制造业提出了相关建议，主要是调整产业结构，降低大宗原料药的比重，增加高附加值的生物制药的生产；加大科研投入力度，提高行业的创新能力。
[Abstract]:The pharmaceutical industry is not only an important part of the high-tech industry and the strategic emerging industry, but also one of the 15 international industries and one of the fastest-growing sunrise industries in the world, which is divided according to international standards, with high technology and high input. The characteristics of high risk and high return. At the same time, the pharmaceutical industry is one of the ten pillar industries in Hebei Province, is an important development industry. In the pharmaceutical industry of Hebei Province, pharmaceutical manufacturing industry plays a leading role. This paper focuses on the pharmaceutical manufacturing industry in Hebei Province. In the current complex economic situation at home and abroad, the increasingly fierce market competition, the price limit of drug policy, and other uncertain factors, such as the bidding policy for "double envelopes" base medicines, the pharmaceutical manufacturing industry in Hebei Province has maintained a steady growth in scale. Innovation and structural adjustment show the characteristics of initial effect. But at the same time also faces many challenges, the total economic volume in the national position behind, the benefit obviously falls, the export situation is also unclear. With the introduction of the 12th Five-Year Plan for the Development of Pharmaceutical Industry in Hebei Province and the vigorous development of the pharmaceutical industry, it is of great significance to study how Hebei Province can cope with the complex external economic environment and adjust its development path to ensure the same increase in revenue and profits. Based on the theory of industrial competitiveness, this paper defines how to study the competitiveness of pharmaceutical manufacturing industry in Hebei Province, and then applies the method of comprehensive comparative advantage coefficient. The deviation-share method and factor analysis method are used to analyze the competitiveness of Hebei pharmaceutical manufacturing industry. Finally, the case of Chinese pharmaceutical group is cited to verify the existing problems in the development of pharmaceutical manufacturing industry in Hebei province. It is found that the problems of pharmaceutical manufacturing industry in Hebei Province are not obvious in scale advantage, structure still needs adjustment; the level of benefit falls sharply; and the level of innovation is not high. Finally, the following conclusions are drawn: the pharmaceutical manufacturing industry in Hebei Province has no comparative advantage over other leading industries, and the pharmaceutical and proprietary Chinese medicine manufacturing industries in Hebei Province do not have a competitive advantage. Chemical preparation industry has a strong competitiveness, although other industries have a certain competitiveness, but the scale is very small; compared with strong pharmaceutical provinces, Hebei Province's pharmaceutical manufacturing industry is in a disadvantaged position. In view of the above conclusions, this paper puts forward some relevant suggestions for the development of pharmaceutical manufacturing industry in Hebei Province in the future, mainly to adjust the industrial structure, reduce the proportion of bulk API, increase the production of high value-added biopharmaceuticals, and increase the investment in scientific research. Improve the innovation ability of the industry.
【学位授予单位】：河北经贸大学
【学位级别】：硕士
【学位授予年份】：2014
【分类号】：F426.72
本文编号：2188416
[Abstract]:The pharmaceutical industry is not only an important part of the high-tech industry and the strategic emerging industry, but also one of the 15 international industries and one of the fastest-growing sunrise industries in the world, which is divided according to international standards, with high technology and high input. The characteristics of high risk and high return. At the same time, the pharmaceutical industry is one of the ten pillar industries in Hebei Province, is an important development industry. In the pharmaceutical industry of Hebei Province, pharmaceutical manufacturing industry plays a leading role. This paper focuses on the pharmaceutical manufacturing industry in Hebei Province. In the current complex economic situation at home and abroad, the increasingly fierce market competition, the price limit of drug policy, and other uncertain factors, such as the bidding policy for "double envelopes" base medicines, the pharmaceutical manufacturing industry in Hebei Province has maintained a steady growth in scale. Innovation and structural adjustment show the characteristics of initial effect. But at the same time also faces many challenges, the total economic volume in the national position behind, the benefit obviously falls, the export situation is also unclear. With the introduction of the 12th Five-Year Plan for the Development of Pharmaceutical Industry in Hebei Province and the vigorous development of the pharmaceutical industry, it is of great significance to study how Hebei Province can cope with the complex external economic environment and adjust its development path to ensure the same increase in revenue and profits. Based on the theory of industrial competitiveness, this paper defines how to study the competitiveness of pharmaceutical manufacturing industry in Hebei Province, and then applies the method of comprehensive comparative advantage coefficient. The deviation-share method and factor analysis method are used to analyze the competitiveness of Hebei pharmaceutical manufacturing industry. Finally, the case of Chinese pharmaceutical group is cited to verify the existing problems in the development of pharmaceutical manufacturing industry in Hebei province. It is found that the problems of pharmaceutical manufacturing industry in Hebei Province are not obvious in scale advantage, structure still needs adjustment; the level of benefit falls sharply; and the level of innovation is not high. Finally, the following conclusions are drawn: the pharmaceutical manufacturing industry in Hebei Province has no comparative advantage over other leading industries, and the pharmaceutical and proprietary Chinese medicine manufacturing industries in Hebei Province do not have a competitive advantage. Chemical preparation industry has a strong competitiveness, although other industries have a certain competitiveness, but the scale is very small; compared with strong pharmaceutical provinces, Hebei Province's pharmaceutical manufacturing industry is in a disadvantaged position. In view of the above conclusions, this paper puts forward some relevant suggestions for the development of pharmaceutical manufacturing industry in Hebei Province in the future, mainly to adjust the industrial structure, reduce the proportion of bulk API, increase the production of high value-added biopharmaceuticals, and increase the investment in scientific research. Improve the innovation ability of the industry.
【学位授予单位】：河北经贸大学
【学位级别】：硕士
【学位授予年份】：2014
【分类号】：F426.72
【引证文献】
相关期刊论文 前2条
1 孙志颖;司贺龙;王秀伶;杨学举;;基于“实践能力培养路线图”的本科专业改革——以河北农业大学制药工程专业为例[J];河北农业大学学报(农林教育版);2015年02期
2 杜宏巍;王文超;;河北省医药制造产业发展现状分析及对策建议[J];中国市场;2015年30期
本文编号：2188416
本文链接：https://www.wllwen.com/jingjilunwen/gongyejingjilunwen/2188416.html
